Mast Cell Activation Syndrome, Histamine and Histamine Intolerance

Mast Cell Activation Syndrome, or MCAS, is one of those conditions that seems to arrive wearing a dozen different disguises. One week it looks like gut trouble, the next like flushing, headaches, a racing heart, itchy eyes, or a wave of fatigue that comes from nowhere. For some people the reactions are mild and merely puzzling; for others they are severe and frightening. Because the symptoms wander across so many body systems and rarely follow a tidy pattern, MCAS is easy to miss, easy to over-diagnose, and genuinely difficult to pin down.

I want to walk through what MCAS actually is, how it is properly diagnosed, and two areas that I think are underexplained elsewhere: the way your body handles histamine, and the kinds of "immune events" that can prime mast cells to misbehave in the first place. My aim is to give you an accurate map, not a checklist to diagnose yourself with, because the single most valuable thing in this area is a careful, well-timed clinical process rather than any one result.

What mast cells are, and what MCAS is

Mast cells are immune cells that sit throughout the body, concentrated in the places that meet with things that come into contact with “the outside world”: the gut lining (for example coming into contact with food you), the skin (coming into contact with things you touch or wear), the airways, and around blood vessels. They are meant to be first responders. When they detect a threat, they release a package of chemical messengers, or mediators, including histamine, tryptase, prostaglandins and leukotrienes. In the right amount, this is protective.

In MCAS, that release mechanism becomes trigger-happy. Mast cells begin discharging their mediators too readily, and in response to things that should be harmless, such as certain foods, smells, temperature changes, stress or hormonal shifts. Because mast cells are everywhere, the fallout can appear almost anywhere, which is exactly why the picture is so scattered and why two people with MCAS can present with different symptoms.

It helps to separate two ideas that often get blurred, and that is the difference between MCAS and a histamine intolerance or clearing issue. MCAS is a problem of mast cells releasing too much histamine (and in fact histamine is just one of a bunch of chemical messengers or mediators that mast cells release). Histamine intolerance, which I will come back to, is a problem of the body clearing histamine too slowly. They can overlap and they can be confused for one another, but they are not the same thing, and telling them apart changes your approach to treatment or what you do about them.

Why MCAS is hard to diagnose, and how it is actually done

Here is where a lot of confusion online creeps in. MCAS is not diagnosed on symptoms alone, however suggestive they are, even though the clinical picture is relevant. The internationally used consensus criteria require three factors to be satisfied together, and the reason they are strict is to avoid labelling people with a mast cell disorder they do not have.

The first requirement is recurrent, episodic symptoms typical of mast cell mediators, affecting at least two organ systems. A gut-only picture, however severe, does not meet the bar on its own. For a diagnosis there need to be episodes that pull in a second system, such as the skin, the airways and eyes, the cardiovascular system, or the nervous system. Noteworthy here, there are not always skin reactions though, no skin flareups or involvement does not exclude MCAS.

The second requirement is objective evidence that mast cells released their mediators during an episode. The most reliable marker is a transient rise in serum tryptase, measured against the person's own baseline, using what is often called the "20% plus 2" rule: the tryptase during a flare should be at least 20% above baseline plus another 2 ng/mL. The catch, and it is a big one, is timing. That blood needs to be drawn within a few hours of a reaction, because tryptase rises and falls quickly. A tryptase taken on a calm day tells you almost nothing, and this is precisely where many workups quietly fail. Where a timed tryptase is not possible, a 24-hour urine test for mast cell mediators, such as N-methylhistamine or a prostaglandin metabolite, is a useful alternative because these are more stable in urine.

The third requirement is a clear improvement in symptoms when treatments that target mast cells or their mediators are used, such as antihistamines. A genuine response to these is not just relief, it is diagnostically relevant information in its own right. (Noteworthy here is there are two classes of antihistamines, H1 and H2, which target different receptors. Within the H1 class you get the ones that cross the blood-brain barrier and the ones that don’t, the ones that don’t are considered non-drowsy. H1 antihistamines target H1 receptors found in the respiratory tract, blood vessels and skin and can help ease symptoms like sneezing and itching and calming redness, whereas H2 antihistamines work on H2 receptors located in the stomach lining and can help with symptoms like acid reflux and heartburn.)

Alongside all this, a good clinician will want to exclude related conditions, particularly mastocytosis and other clonal mast cell disease, and will keep hereditary alpha-tryptasemia in mind as a cause of a raised baseline tryptase. This is medical territory, and it is why MCAS is best worked up in partnership with a GP or specialist rather than chased through symptoms and supplements alone.

A few honest lessons I would pass on from clinical practice. A normal resting histamine or a normal baseline tryptase does not rule MCAS out; between episodes, those numbers are expected to look ordinary. The most useful thing you can do is capture a sample during or just after a bad flare, so if you feel one building, that is the moment to get to pathology quickly. And a strong response to an antihistamine is worth taking seriously as an indicator and recording it, rather than dismissing it as coincidence. If you are unwell and an antihistamine relieves your symptoms, report this to your practitioner.

Histamine and its three routes: why "normal" bloods can mislead

Histamine deserves its own section, because understanding how the body makes and breaks it down explains a lot of the confusion around testing.

Your body produces histamine from the amino acid histidine, and stores it in mast cells and basophils. You also take it in through food, especially aged, fermented and leftover foods, and your gut bacteria produce some of their own. While some foods contain histamine (like fermented and aged foods), others are considered histamine liberators as they can trigger a release of histamine from your body (such as citrus fruit for example). So the total histamine load at any moment is a mix of what you release internally and what arrives from outside.

Getting rid of it relies on a small number of pathways, and this is the part worth knowing.

The first route is DAO (diamine oxidase). This enzyme works outside the cells, and it is concentrated in the lining of the small intestine and the kidneys. Think of DAO as the gatekeeper at the gut wall: its main job is to break down histamine from food and from gut bacteria before it can cross into the bloodstream. DAO depends on nutrients including copper, vitamin B6 and vitamin C to do its work, and its activity can be knocked down by alcohol and by certain medications. When DAO is overwhelmed or underactive, dietary histamine slips through, and this is the mechanism behind classic histamine intolerance.

The second route is HNMT (histamine N-methyltransferase). This enzyme works inside the cells, throughout the liver, kidneys, airways and brain, and it is actually the larger contributor to histamine breakdown overall as well as the only route available in the brain. HNMT uses a methyl group donated by a molecule called SAMe to do its job, which means it leans on the body's methylation machinery, and therefore on nutrients like folate and vitamin B12. So a person's histamine clearance is tied, in part, to how well they methylate.

The third route is the downstream step. The main product of the HNMT pathway, N-methylhistamine, is then further processed by another enzyme (monoamine oxidase) before being excreted. This matters practically, because N-methylhistamine is exactly what a 24-hour urine test measures, and it is one of the mediators used to help confirm MCAS. In other words, the histamine breakdown pathway and the MCAS testing pathway are the same road viewed from two ends.

This is why a single blood histamine level so often disappoints. Histamine has a very short life in the blood and its release is episodic, so a resting sample is frequently normal even in someone who clearly has a histamine problem. If histamine is going to be assessed, the more informative options are a 24-hour urinary N-methylhistamine, which is steadier and doubles as a mast cell mediator test, and, where a clearance problem is suspected, a look at DAO activity. A normal snapshot blood level should never be read as closing the question.

The connection back to MCAS is straightforward once you see it. If mast cells are releasing extra histamine, and the DAO or HNMT clearance routes are limited by genetics, nutrient shortfalls, alcohol or medications, you get a double hit: more histamine arriving, and less being cleared. Supporting those clearance pathways does not treat MCAS, but it can lower the overall load, which is often why a targeted low-histamine approach helps even when the underlying problem is release rather than clearance.

Where methylation fits in (and where it doesn't)

This is worth unpacking, because "methylation," "MTHFR" and "homocysteine" are terms people hear thrown around constantly, especially in connection with histamine, without ever being shown how they connect, or where the popular story runs ahead of the evidence.

Here is the genuine connection. The HNMT route above works by attaching a methyl group to histamine, and it borrows that methyl group from a molecule called SAMe. Methylation is one way the body clears histamine. A methyl group is just a small chemical tag the body moves from one molecule to another to switch processes on or off, and SAMe is the main "delivery van" that carries those tags around, which is why it is described as the body's main methyl donor. SAMe is continually regenerated by the methylation cycle, a piece of everyday biochemistry that runs on folate, vitamin B12 and vitamin B6. So the HNMT pathway is, in effect, plugged into your methylation system. If methylation is genuinely under-resourced, for example through poor B-vitamin status or heavy demand elsewhere, it is biologically reasonable that HNMT clears histamine a little less efficiently, and that you therefore tolerate a given histamine load less comfortably. This is also where homocysteine earns its keep as a test: homocysteine is a by-product of the methylation cycle, so a raised level is a practical, functional signal that the cycle may be struggling, even when a standard B12 level looks acceptable. (Often high histamine levels are correlated with undermethylation, which is the connection you may have heard about.)

Now the important caution, because this is where the terms get overstretched. You will often see a straight line drawn from an MTHFR gene variant, to "impaired methylation," to histamine problems, to MCAS. Each of those links is weaker than it is usually made to sound. MTHFR variants are very common, most people who carry them methylate perfectly well, and there is little to no solid evidence tying MTHFR status to MCAS specifically, which is an important point to make. More fundamentally, methylation affects how efficiently you clear histamine; it does not make mast cells release their mediators inappropriately, and that release is what MCAS actually is. So methylation is best understood as a modifier of histamine tolerance and of your background histamine burden because of its role in histamine clearance, not as a cause of the mast cell activation itself. Supporting it may help someone cope with their total load, which is a worthwhile lever, but it is a downstream one. Holding that distinction is what stops "I have an MTHFR variant" from turning into a diagnosis it was never able to support. In terms of nutrition lens though, there is a way to hold this together. Each of the two histamine-clearance enzymes has its own nutritional dependency: DAO leans on copper, vitamin B6 and vitamin C, while HNMT leans on the methylation nutrients, folate and B12. Seen as a matched pair, the practical message is simple and un-hyped: nutrient status on both sides of the clearance system matters, and in someone who has eaten a narrow diet for a long time, both sides are worth checking. However an important take away here is both poor methylation and Mast Cell Activation Syndrome (MCAS) can cause elevated histamine levels, but one is a clearance problem, and the other is an overproduction problem, so high histamine on its own is not enough of a marker to diagnose either on its own.

Back to MCAS: What counts as an "immune event"

A phrase I find useful is that root causes load the gun and triggers pull it. Many people can point to a moment when their symptoms began, and that moment is often what I would loosely call an immune event: something that stressed or activated the immune system enough to shift mast cells into a more reactive state.

These events take many forms, and it is worth recognising the range rather than looking only for an obvious allergy. They include:

• Infections of almost any kind, including viral, bacterial, and gut infections
• Viral reactivation patterns, where an old virus flares
• COVID infection and the longer tail of post-viral illness that can follow it
• Immunisations, which by design provoke an immune response
• Surgery, injury or other significant physical trauma
• Severe or sustained emotional stress
• A serious allergic or anaphylactic reaction
• Prolonged exposure to mould and mycotoxins, or to significant chemical irritants

None of these guarantees MCAS, and most people who experience them are fine. But in someone who goes on to develop unexplained, multi-system, flare-like symptoms, the timing of onset relative to one of these events is a meaningful piece of the story, and worth mapping out carefully.

Compounding factors worth considering

MCAS rarely travels alone, and several background factors can amplify it or muddy the diagnosis. These are the ones I keep front of mind.

The gut. The gut is one of the densest mast cell environments in the body, so gut disruption and mast cell reactivity feed each other. Small intestinal bacterial overgrowth (SIBO) and dysbiosis are common companions, and they cut two ways: they can genuinely worsen mast cell activation, and they can also mimic it, producing bloating, cramping and food reactions that look similar. Settling the gut often lowers the histamine load and reduces flares, which is one reason gut work earns its place in a plan. Not to mention, a healthy gut is better at absorbing nutrients, whereas deficiencies can cripple an already overloaded system further.

Oestrogen and perimenopause. Oestrogen influences mast cell activity and can reduce DAO, which is part of why symptoms often shift across the menstrual cycle, in perimenopause and in pregnancy. There is a subtle trap here worth naming: perimenopause produces its own flushing, palpitations, brain fog and sleep disturbance, and those are exactly the sort of second-system clues that help establish MCAS. It is easy to file them under "perimenopause" or “menopause” symptoms and therefore not think to mention them to your practitioner, meaning the full picture stays hidden, risking un-diagnosis. The useful question is one of timing: do the flushes or palpitations cluster around eating or around a flare, rather than occurring at random?

Nutrient status. Because DAO relies on copper, B6 and vitamin C, and HNMT relies on methylation nutrients like folate and B12, a depleted diet can quietly reduce histamine clearance. In someone who has been eating a narrow diet for a long time, this is a real consideration rather than a theoretical one.

Nervous system load. Mast cells respond to stress signals directly, so a chronically activated nervous system can amplify reactivity. This is why stress regulation and recovery practices and good habits like enough sleep, paced activity, breathwork and genuine downtime are not light ideals, they form part of a therapeutic protocol.

Overlapping conditions. MCAS often keeps company with dysautonomia (including POTS) and with hypermobility conditions. Where these coexist, they need to be recognised, because each has its own management.

A sound, unhurried approach

If there is one theme that ties all of this together, it is that MCAS rewards structure and punishes guesswork. The most sustainable progress usually comes from confirming or excluding the diagnosis properly, using the right tests at the right time; reducing the daily triggers that drive flares; supporting mast cell stability through clinician-directed care; and then addressing the background drivers such as gut health, nutrient status, hormones, stress physiology and any lingering immune load.

On the nutrition side specifically, a low-histamine approach can be genuinely helpful, but it should be a targeted, temporary trial with a clear plan to reintroduce foods, not an indefinite state of restriction (because this can risk deficiencies). Long, fearful, overly restrictive diets carry their own cost in nutrition and quality of life, and they are hardly ever necessary indefinitely. The goal is always the broadest diet your body is comfortable with, not the narrowest.

When to seek help

If your symptoms are multi-system, come in flares, and have never quite added up to a single diagnosis, MCAS is a reasonable thing to explore, ideally alongside a GP who can arrange the timed testing that makes the picture clear. If there is any history of severe allergic reactions or anaphylaxis, that needs a medical emergency plan, and that conversation should happen with a doctor as a priority.

The reassuring part is that once you break MCAS down into its parts, what feels like a body reacting to everything usually turns out to be a smaller number of drivers that can be worked through methodically. That is the difference between chasing symptoms and following a plan.

This article is general information and is not a substitute for individual medical advice. Diagnosis of MCAS, and any prescribed treatment, should be guided by your doctor, and ideally managed with a team of doctor and nutrition specialist.

Sources and further reading

• Valent P, Akin C, Bonadonna P, et al. Consensus diagnostic criteria and classification of mast cell activation disorders (originally Int Arch Allergy Immunol 2012; updated proposals, J Allergy Clin Immunol Pract 2022).
• Weiler CR, et al. and the "20% + 2" tryptase formula literature on documenting mast cell mediator release.
• The Mast Cell Disease Society (tmsforacure.org): patient-facing overview of MCAS diagnosis.
• Mayo Clinic Laboratories: urinary mast cell mediator testing.
• StatPearls, Biochemistry, Histamine (NIH/NCBI Bookshelf): histamine synthesis and the HNMT and DAO degradation pathways.
• Comas-Basté O, et al. and related reviews on histamine intolerance and diamine oxidase.